252 related articles for article (PubMed ID: 3099974)
1. The effects of pyridinium salts, structurally related compounds of 1-methyl-4-phenylpyridinium ion (MPP+), on tyrosine hydroxylation in rat striatal tissue slices.
Hirata Y; Sugimura H; Takei H; Nagatsu T
Brain Res; 1986 Nov; 397(2):341-4. PubMed ID: 3099974
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of tyrosine hydroxylation in rat striatal tissue slices by 1-methyl-4-phenylpyridinium ion.
Hirata Y; Nagatsu T
Neurosci Lett; 1985 Jun; 57(3):301-5. PubMed ID: 3929190
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of the tyrosine hydroxylase system by MPTP, 1-methyl-4-phenylpyridinium ion (MPP+) and the structurally related compounds in vitro and in vivo.
Nagatsu T; Hirata Y
Eur Neurol; 1987; 26 Suppl 1():11-5. PubMed ID: 2884110
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of tyrosine hydroxylation in tissue slices of the rat striatum by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
Hirata Y; Nagatsu T
Brain Res; 1985 Jun; 337(1):193-6. PubMed ID: 2860954
[TBL] [Abstract][Full Text] [Related]
5. MPP+-induced increases in extracellular potassium ion activity in rat striatal slices suggest that consequences of MPP+ neurotoxicity are spread beyond dopaminergic terminals.
Hollinden GE; Sanchez-Ramos JR; Sick TJ; Rosenthal M
Brain Res; 1988 Dec; 475(2):283-90. PubMed ID: 3265070
[TBL] [Abstract][Full Text] [Related]
6. The effects of 1-methyl-4-phenylpyridinium ion (MPP+) on the efflux and metabolism of endogenous dopamine in rat striatal slices.
Snape BM; Pileblad E; Ekman A; Magnusson T; Carlsson A; Engel J
J Pharm Pharmacol; 1988 Sep; 40(9):620-6. PubMed ID: 2907028
[TBL] [Abstract][Full Text] [Related]
7. Dopamine-releasing action of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and 1-methyl-4-phenylpyridine (MPP+) in the neostriatum of the rat as demonstrated in vivo by the push-pull perfusion technique: dependence on sodium but not calcium ions.
Sirinathsinghji DJ; Heavens RP; McBride CS
Brain Res; 1988 Mar; 443(1-2):101-16. PubMed ID: 3258784
[TBL] [Abstract][Full Text] [Related]
8. 1-Methyl-4-phenylpyridinium (MPP+) increases oxidation of cytochrome-b in rat striatal slices.
Sanchez-Ramos JR; Hollinden GE; Sick TJ; Rosenthal M
Brain Res; 1988 Mar; 443(1-2):183-9. PubMed ID: 3258785
[TBL] [Abstract][Full Text] [Related]
9. Inactivation of tyrosine hydroxylase in rat striatum by 1-methyl-4-phenylpyridinium ion (MPP+).
Ozaki N; Nakahara D; Mogi M; Harada M; Kiuchi K; Kaneda N; Miura Y; Kasahara Y; Nagatsu T
Neurosci Lett; 1988 Feb; 85(2):228-32. PubMed ID: 2897647
[TBL] [Abstract][Full Text] [Related]
10. Serotonergic conversion of MPTP and dopaminergic accumulation of MPP+.
Shen RS; Abell CW; Gessner W; Brossi A
FEBS Lett; 1985 Sep; 189(2):225-30. PubMed ID: 3876242
[TBL] [Abstract][Full Text] [Related]
11. Studies on the neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: inhibition of NAD-linked substrate oxidation by its metabolite, 1-methyl-4-phenylpyridinium.
Vyas I; Heikkila RE; Nicklas WJ
J Neurochem; 1986 May; 46(5):1501-7. PubMed ID: 3485701
[TBL] [Abstract][Full Text] [Related]
12. Acute effects of 1-methyl-4-phenylpyridinium ion (MPP+) on dopamine and serotonin metabolism in rat striatum as assayed in vivo by a micro-dialysis technique.
Ozaki N; Nakahara D; Kaneda N; Kiuchi K; Okada T; Kasahara Y; Nagatsu T
J Neural Transm; 1987; 70(3-4):241-50. PubMed ID: 3500274
[TBL] [Abstract][Full Text] [Related]
13. Effects of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and its metabolite, N-methyl-4-phenylpyridinium ion, on dopaminergic nigrostriatal neurons in the mouse.
Perry TL; Yong VW; Jones K; Wall RA; Clavier RM; Foulks JG; Wright JM
Neurosci Lett; 1985 Aug; 58(3):321-6. PubMed ID: 3876525
[TBL] [Abstract][Full Text] [Related]
14. Evidence for the release of 1-methyl-4-phenylpyridinium (MPP+) from rat striatal neurons in vitro.
Keller HH; Da Prada M
Eur J Pharmacol; 1985 Dec; 119(3):247-50. PubMed ID: 3879221
[TBL] [Abstract][Full Text] [Related]
15. Dopaminergic toxicity of rotenone and the 1-methyl-4-phenylpyridinium ion after their stereotaxic administration to rats: implication for the mechanism of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity.
Heikkila RE; Nicklas WJ; Vyas I; Duvoisin RC
Neurosci Lett; 1985 Dec; 62(3):389-94. PubMed ID: 3912685
[TBL] [Abstract][Full Text] [Related]
16. 1-Methyl-4-phenylpyridinium uptake by human and rat striatal synaptosomes.
Willoughby J; Cowburn RF; Hardy JA; Glover V; Sandler M
J Neurochem; 1989 Feb; 52(2):627-31. PubMed ID: 2783454
[TBL] [Abstract][Full Text] [Related]
17. Astrocytes as a primary locus for the conversion MPTP into MPP+.
Brooks WJ; Jarvis MF; Wagner GC
J Neural Transm; 1989; 76(1):1-12. PubMed ID: 2785159
[TBL] [Abstract][Full Text] [Related]
18. An in vitro model of 1-methyl-4-phenyl-pyridinium (MPP+) toxicity: incubation of rabbit caudate nucleus slices with MPP+ followed by biochemical and functional analysis.
Feuerstein TJ; Hedler L; Jackisch R; Hertting G
Br J Pharmacol; 1988 Oct; 95(2):449-58. PubMed ID: 3265882
[TBL] [Abstract][Full Text] [Related]
19. MPTP, MPP+ and mitochondrial function.
Nicklas WJ; Youngster SK; Kindt MV; Heikkila RE
Life Sci; 1987 Feb; 40(8):721-9. PubMed ID: 3100899
[TBL] [Abstract][Full Text] [Related]
20. Behavioral and biochemical changes following acute administration of MPTP and MPP+.
Tadano T; Satoh N; Sakuma I; Matsumura T; Kisara K; Arai Y; Kinemuchi H
Life Sci; 1987 Mar; 40(13):1309-18. PubMed ID: 2436017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
